# Observational GORE® VIABAHN® Endoprosthesis With PROPATEN Bioactive Surface Global Registry

> **NCT04907240** · — · ACTIVE_NOT_RECRUITING · sponsor: **W.L.Gore & Associates** · enrollment: 614 (estimated)

## Conditions studied

- Peripheral Artery Disease
- Popliteal Aneurysm
- Hemodialysis Access
- Visceral Artery Aneurysms
- Trauma Injury

## Interventions

- **DEVICE:** GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface (VSX)

## Key facts

- **NCT ID:** NCT04907240
- **Lead sponsor:** W.L.Gore & Associates
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-10-09
- **Primary completion:** 2026-10
- **Final completion:** 2035-10
- **Target enrollment:** 614 (ESTIMATED)
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04907240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04907240, "Observational GORE® VIABAHN® Endoprosthesis With PROPATEN Bioactive Surface Global Registry". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04907240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*